Skip to main content

Duke Neurology at AAN 2017: Highlights from Boston

Friday, April 28, 2017

As the American Academy of Neurology’s 2017 conference wraps up in Boston, we thought we’d review the contributions Duke Neurology made to the meeting. More than 20 faculty, residents, and fellows presented posters, taught courses, or led discussions on topics ranging from the history of American Neurology to how to better perform concussion examinations after a sports injury. Click here to view an album of photos from the conference, or read more about our Department’s contributions below.

Panel Presentations:

  • Jennifer Creed, MD, PhD, (photo) led a discussion of her ongoing research project with Daniel Laskowitz, MD, MHS, and Duke Anesthesiology’s Ulrike Hoffmann, MD, PhD, which examined the use of argon as a neuroprotective agent in mice with traumatic brain injuries.
  • Shruti Raja, MD, presented a case of brachiocervical inflammatory myopathy in a session focusing on unusual neuromscular disease. 

Poster presentations

  • Suma Das, MD, Karissa Gable, MD, and Vern Juel, MD examined whether review sessions improve student performance on the NBME subject examination. Read what they found out here.
  • Jeff Guptill, MD, MHS, Don Sanders, MD, and colleagues discussed using lessons they learned from patients to improve treatment for myasthenia gravis. Read their abstract here.   
  • Jennifer Creed, MD, PhD, E. Wayne Massey, MD, and M. Tariq Bhatti, MD discussed four cases where the Scottish surgeon Argyll Robinson described miotic pupils. Read their findings here.
  • In another history-based poster, Massey, along with recent Duke Neurology alum Eric Prince, MD, discusses American neurologist (and former Surgeon General) William Hammond’s perspective on the assassination of President James Garfield.  Read what they found here.
  • Daniel Harrison (MS-3, Duke School of Medicine), and Rick Bedlack, MD, PhD, uncover and discuss demographic characteristics of individuals who have undergone ALS reversals. Read their abstract here.
  • Mark Stacy, MD, and colleagues examined whether topiramate reduced dyskinesia in Parkinson’s patients who were already taking amantadine. Read their abstract here.
  • Katherine Heller, PhD, and F. Lee Hartsell, MD, MHS discuss how their MS Mosaic iPhone app will improve data collection about multiple sclerosis symptoms. Read their abstract here.
  • Rodney Radtke, MD, was part of a team that analyzed how ESL, a therapy for partial-onset seizures, affected plasma sodium levels. View their poster here.
  • Saurabh Sinha, MD, PhD, also contributed toward a poster examining ESL, this time examining long-term safety and efficacy outcomes when ESL was used as a monotherapy. View their poster here.
  • Clinical neurophysiology fellow Eric Arehart, MD, PhD, Mohamad Mikati, MD, and colleagues examined whether Lamotrigine protects against acute hypoxia in a rat model. Read what they found here.
  • Stroke fellow Matthew Ehrlich, MD, contributed toward a poster examining enrollment in BEAST, an international effort to identify genetic determinants for cerebral venous sinus thrombosis. Read their abstract here.
  • Movement disorders fellow Anna Bjornsdottir, MD, and colleagues wrote a case report discussing a 31-year old male patient with acute left thalamic infarction experiencing isolated pseudoabducens palsy. Read their abstract here.


  • Aatif Husain, MD, taught a course reviewing important aspects of continuous EEG (cEEG) monitoring in critically ill patients
  • Joel Morgenlander, MD, led a section of a sports concussion skills workshop focusing on concussion-specific history and examinations.
  • Janice Massey, MD, FAAN, and Jeff Guptill, MD, taught sections of a course discussing diagnosis and care for patients with myasthenia gravis.
  • Vern Juel, MD, taught the neuromuscular portion of a MOC review course, and gave a lecture in a course on neuromuscular testing and quantitative EMG.